Journal Article

Prevalence of breast, cervical, and colorectal cancer screenings among select New York City populations

Foster, Victoria, Yusuf, Yousra, Sifuentes, Sonia, Wyatt, Laura C., Kwon, Simona C., Trinh-Shevrin, Chau, Nguyễn, Charlie H., Kranick, Julie, LeCroy, Madison N.

2025

Overview

Background Prior studies have found racial and ethnic disparities in cancer screenings, yet smaller minority ethnic groups are often aggregated. Methods Data from the 2021–2022 Community Health Resources and Needs Assessment (Cancer CHRNA) and the 2017–2020 NYC Community Health Survey (CHS) examined the prevalence of breast, cervical, and colorectal cancer screenings among Eastern European, Afro-Caribbean, Latine, Chinese, Korean, South Asian, and Southwest Asian and North African (SWANA) groups in New York City. Multivariable logistic regression models estimated adjusted relative risks of cancer screening outcomes by group. Results Up-to-date mammogram screening was low (< 70%) among all groups except Afro-Caribbean in the Cancer CHRNA; and among South Asian, Chinese, and Eastern European groups in the CHS. In logistic regression, South Asian and SWANA groups were less likely to have received an up-to-date mammogram compared to the Afro-Caribbean group in the Cancer CHRNA; no group differences were found in the CHS. Up-to-date Pap screening was low (< 70%) among all groups except Latina in the Cancer CHRNA; and among South Asian and Chinese groups in the CHS. In logistic regression, all other groups were less likely to have received an up-to-date Pap test compared to the Latina group in the Cancer CHRNA; and Chinese and South Asian groups were less likely to have received an up-to-date Pap test compared to the Latina group in the CHS. Up-to-date colonoscopy screening was low (< 70%) among all groups in the Cancer CHRNA; and among SWANA, South Asian, Chinese, and Eastern European groups in the CHS. In logistic regression, all groups except Chinese were less likely to have received an up-to-date colonoscopy compared to the Eastern European group in the Cancer CHRNA; and the Chinese and SWANA groups were less likely to have received an up-to-date colonoscopy compared to the Afro-Caribbean group in the CHS. Conclusions Disparities in cancer screenings differed by screening type and survey, with larger disparities found among groups in the Cancer CHRNA. System level efforts are needed to monitor cancer screening disparities by disaggregating diverse groups; culturally tailored strategies should be used to raise awareness to increase screening. Clinical trial information Not applicable.

• Publisher: BioMed Central,BioMed Central Ltd,Springer Nature B.V,BMC
• Subject: Adult / Aged / Analysis / Asian Americans / Biomedical and Life Sciences / Biomedicine / Breast / Breast cancer / Breast Neoplasms - diagnosis / Cancer / Cancer Research / Cancer screening / Cervical cancer / Colonoscopy / Colorectal carcinoma / Colorectal Neoplasms - diagnosis / Demographic aspects / Diagnosis / Early Detection of Cancer - statistics & numerical data / Economic aspects / Ethnic and racial minorities / Ethnicity - statistics & numerical data / Female / Health care access / Health care disparities / Health Promotion and Disease Prevention / Health surveys / Healthcare Disparities - ethnology / Healthcare Disparities - statistics & numerical data / Humans / Hysterectomy / Immigrants / Male / Mammography / Mammography - statistics & numerical data / Medical screening / Medicine/Public Health / Mental health / Middle Aged / Minority & ethnic groups / New York City / Oncology / Pacific Islander people / Pap smear / Papanicolaou test / Population studies / Prevalence / Regression analysis / Risk assessment / Social aspects / Sociodemographics / Surgical Oncology / Surveys / Urban population / Uterine Cervical Neoplasms - diagnosis / Womens health